Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
Abstract
No abstract availableKeywords
Funding Information
- Professor T. Rajagopalan Research (TRR /SASTRA / April-2014 /MJR)
This publication has 185 references indexed in Scilit:
- Polymer Nanoparticle-Mediated Delivery of MicroRNA Inhibition and Alternative SplicingMolecular Pharmaceutics, 2012
- MicroRNA therapeuticsGene Therapy, 2011
- p53 spreads out further: suppression of EMT and stemness by activating miR-200c expressionCell Research, 2011
- Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liverGene Therapy, 2010
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 #Hepatology, 2009
- miR-200 Regulates PDGF-D-Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer CellsStem Cells, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- MicroRNA expression profiles of esophageal cancerThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes ApoptosisMolecular Cell, 2007
- MicroRNAs and their regulatory roles in animals and plantsJournal of Cellular Physiology, 2006